Showing results (11-20 of 192) with videos related to
Sort By:
Pageof 20
Endocrine Connections|August 18, 2025
Mutational landscapes of HNF MODY gene products display a wide distribution with functional implicationsYoung-In Chi, Raul UrrutiaExpert Opinion on Drug Discovery|March 19, 2013
Applications of microarray technology to pancreatic cancer research and drug developmentMark J Truty, Raul UrrutiaJournal of Gastrointestinal Cancer|February 22, 2011
Polycomb and the emerging epigenetics of pancreatic cancerAdrienne Grzenda, Tamas Ordog, Raul UrrutiaGenome Biology|March 7, 2003
Sp1- and Krüppel-like transcription factorsJoanna Kaczynski, Tiffany Cook, Raul UrrutiaJournal of Gastrointestinal Cancer|June 11, 2009
Interplay of tumor microenvironment cell types with parenchymal cells in pancreatic cancer development and therapeutic implicationsPraveen Guturu, Vijay Shah, Raul UrrutiaPancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 27, 2008
Primers on molecular pathways--pain and opioid receptors, IGwen Lomberk, Ricardo Cruciani, Raul UrrutiaGenome Biology|January 17, 2007
The Heterochromatin Protein 1 familyGwen Lomberk, Lori Wallrath, Raul UrrutiaEpigenomics|June 24, 2016
The promise of epigenomic therapeutics in pancreatic cancerGwen A Lomberk, Juan Iovanna, Raul UrrutiaMolecular Cancer Research : MCR|December 31, 2014
Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?Ningling Kang, Vijay H Shah, Raul UrrutiaCurrent Opinion in Gastroenterology|August 12, 2005
When developmental signaling pathways go wrong and their impact on pancreatic cancer developmentGwen Lomberk, Martin E Fernandez-Zapico, Raul UrrutiaPageof 20